Sanofi Adr Stock Overlap Studies Triple Exponential Moving Average T3
| SNY Stock | USD 48.49 0.23 0.47% |
| Symbol |
The output start index for this execution was fifty-four with a total number of output elements of seven. The Triple Exponential Moving Average (T3) indicator is developed by Tim Tillson as Sanofi ADR price series composite of a single exponential moving average, a double exponential moving average and a triple exponential moving average.
Sanofi ADR Technical Analysis Modules
Most technical analysis of Sanofi ADR help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Sanofi from various momentum indicators to cycle indicators. When you analyze Sanofi charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Sanofi ADR Predictive Technical Analysis
Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Sanofi ADR. We use our internally-developed statistical techniques to arrive at the intrinsic value of Sanofi ADR based on widely used predictive technical indicators. In general, we focus on analyzing Sanofi Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Sanofi ADR's daily price indicators and compare them against related drivers, such as overlap studies and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Sanofi ADR's intrinsic value. In addition to deriving basic predictive indicators for Sanofi ADR, we also check how macroeconomic factors affect Sanofi ADR price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
| 2021 | 2022 | 2023 | 2024 (projected) | Dividend Yield | 0.0361 | 0.0371 | 0.0396 | 0.0232 | Price To Sales Ratio | 2.83 | 2.48 | 2.44 | 3.95 |
Be your own money manager
As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.Generate Optimal Portfolios
Align your risk and return expectations
Additional Tools for Sanofi Stock Analysis
When running Sanofi ADR's price analysis, check to measure Sanofi ADR's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sanofi ADR is operating at the current time. Most of Sanofi ADR's value examination focuses on studying past and present price action to predict the probability of Sanofi ADR's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sanofi ADR's price. Additionally, you may evaluate how the addition of Sanofi ADR to your portfolios can decrease your overall portfolio volatility.